PDCD1 and cancer: Possible explanations may involve the stimulation of cancer cells or immune cells to secrete immunostimulatory cytokines as a result of TMZ treatment, or the modulation of immunomodulatory receptors or ligands such as PD-1/PD-L1 due to TMZ treatment [78].